Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Astellas Pharma Inc.
ALPMYCurrent price
12.15 USD
+0.44 USD (+3.76%)
Last closed
1 689 JPY
Company
www.astellas.com
ISIN
JP3942400007
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
TSE
Capitalization
3 108 091 723 764 JPY
Yield for 12 month
-20.42 %
1Y
3Y
5Y
10Y
15Y
ALPMY
Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan. Address: 2-5-1, Nihonbashi-Honcho, Tokyo, Japan, 103-8411
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
273 326.91 JPYP/E ratio
145.3138Dividend Yield
4.27 %Current Year
+1 603 672 000 049 JPY
Last Year
+1 518 619 000 035 JPY
Current Quarter
+473 123 999 993 JPY
Last Quarter
+414 601 999 953 JPY
Current Year
+1 212 366 999 963 JPY
Last Year
+1 230 265 999 930 JPY
Current Quarter
+346 995 999 960 JPY
Last Quarter
+308 725 999 979 JPY
Key Figures ALPMY
1 year
3 years
5 years
10 years
EBITDA
279 988 994 054 JPY
Operating Margin TTM
PE Ratio
145.3138
Return On Assets TTM
1.82 %
PEG Ratio
–
Return On Equity TTM
1.32 %
Wall Street Target Price
273 326.91 JPY
Revenue TTM
1 701 805 948 928 JPY
Book Value
936.24 JPY
Revenue Per Share TTM
Dividend Share
70 JPY
Quarterly Revenue Growth YOY
26.2 %
Dividend Yield
4.27 %
Gross Profit TTM
1 043 154 000 000 JPY
Earnings per share
11.95 JPY
Diluted Eps TTM
11.95 JPY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
13.7 %
Profit Margin
1.26 %
Dividend Analytics ALPMY
Champion
- 10+ consecutive years of dividend increases
Dividend growth over 5 years
76 %Continuous growth
10 yearsPayout Ratio 5 years average
67 %Dividend History ALPMY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
74
Ex Dividend Date
27.09.2024
Forward Annual Dividend Yield
4.27 %
Last Split Factor
5:1
Payout Ratio
5.81 %
Last Split Date
27.03.2014
Dividend Date
–
Stock Valuation ALPMY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
145.3138
Forward PE
12.3457
Enterprise Value Revenue
2.1481
Price Sales TTM
1.8263
Enterprise Value EBITDA
16.0856
Price Book MRQ
1.9424
Financials ALPMY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALPMY
For 52 weeks
1 426 JPY
2 088.86 JPY
50 Day MA
1 719.83 JPY
Shares Short Prior Month
–
200 Day MA
1 644.24 JPY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart